Cargando…

Monitoring early dynamic changes of plasma cell-free DNA and pretreatment pre-albumin to predict chemotherapy effectiveness and survival outcomes in advanced non-small cell lung cancer

BACKGROUND: This study aimed to determine whether plasma cell-free DNA (cfDNA) and pretreatment parameters provide useful therapeutic response and prognostic information for advanced non-small cell lung cancer (NSCLC) patients. METHODS: A total of 114 patients with advanced NSCLC who underwent syste...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Jia, Shao, Jingjing, Zhang, Xunlei, Wei, Sheng, Cai, Hongyu, Wang, Gaoren
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8987881/ https://www.ncbi.nlm.nih.gov/pubmed/35402598 http://dx.doi.org/10.21037/atm-22-12

Ejemplares similares

The preoperative hemoglobin, albumin, lymphocyte, and platelet score is a prognostic factor for non-small cell lung cancer patients undergoing adjuvant chemotherapy: a retrospective study
por: Wei, Sheng, et al.
Publicado: (2022)

Glycolytic Genes Predict Immune Status and Prognosis Non-Small-Cell Lung Cancer Patients with Radiotherapy and Chemotherapy
por: Zhao, Tianye, et al.
Publicado: (2023)

The pretreatment albumin to globulin ratio predicts survival in patients with natural killer/T-cell lymphoma
por: Bi, Xi-wen, et al.
Publicado: (2016)

The value of circulating fibrinogen-to-pre-albumin ratio in predicting survival and benefit from chemotherapy in colorectal cancer
por: Ying, Hou-Qun, et al.
Publicado: (2021)

Prognostic Value of the Pretreatment Systemic Immune-Inflammation Index in Patients with Colorectal Cancer
por: Li, Jing, et al.
Publicado: (2020)

Combining the Fibrinogen-to-Pre-Albumin Ratio and Prognostic Nutritional Index (FPR-PNI) Predicts the Survival in Elderly Gastric Cancer Patients After Gastrectomy
por: Zhang, Xunlei, et al.
Publicado: (2020)

Pretreatment Albumin/Globulin Ratio Predicts the Prognosis for Small-Cell Lung Cancer
por: Zhou, Ting, et al.
Publicado: (2016)

Pretreatment albumin/fibrinogen ratio as a promising predictor for the survival of advanced non small-cell lung cancer patients undergoing first-line platinum-based chemotherapy
por: Ying, Jun, et al.
Publicado: (2019)

Pretreatment plasma fibrinogen and serum albumin levels predict therapeutic efficacy of concurrent radiochemotherapy for esophageal squamous cell cancer
por: Wang, Jijin, et al.
Publicado: (2022)

Based on the Development and Verification of a Risk Stratification Nomogram: Predicting the Risk of Lung Cancer-Specific Mortality in Stage IIIA-N2 Unresectable Large Cell Lung Neuroendocrine Cancer Compared With Lung Squamous Cell Cancer and Lung Adenocarcinoma
por: Yang, Ying, et al.
Publicado: (2022)

The prognostic value of pretreatment albumin-to-fibrinogen ratio in small cell lung cancer patients receiving first-line platinum-based chemotherapy
por: Li, Qi, et al.
Publicado: (2023)

Prognostic role of pretreatment serum albumin in renal cell carcinoma: a systematic review and meta-analysis
por: Chen, Zhen, et al.
Publicado: (2016)

Pretreatment serum albumin as a predictor of cancer survival: A systematic review of the epidemiological literature
por: Gupta, Digant, et al.
Publicado: (2010)

Role of cuproptosis-related gene in lung adenocarcinoma
por: Liu, Yuan, et al.
Publicado: (2022)

Predictive value of pretreatment albumin‐to‐alkaline phosphatase ratio for overall survival for patients with advanced non‐small cell lung cancer
por: Zhou, Shaozhang, et al.
Publicado: (2020)

Low expression of PRDM5 predicts poor prognosis of esophageal squamous cell carcinoma
por: Guo, Jing, et al.
Publicado: (2022)

Pretreatment C-reactive protein to albumin ratio for predicting overall survival in advanced pancreatic cancer patients
por: Hang, Junjie, et al.
Publicado: (2017)

Pretreatment serum albumin-to-alkaline phosphatase ratio is an independent prognosticator of survival in patients with metastatic gastric cancer
por: Li, Yu-Ting, et al.
Publicado: (2022)

Plasma cell-free DNA integrity: a potential biomarker to monitor the response of breast cancer to neoadjuvant chemotherapy
por: Wang, Wei, et al.
Publicado: (2019)

Data Pre-Processing for Label-Free Multiple Reaction Monitoring (MRM) Experiments
por: Chung, Lisa M., et al.
Publicado: (2014)

Pretreatment C-reactive protein/albumin ratio for predicting overall survival in pancreatic cancer: A meta-analysis
por: Zang, Ye, et al.
Publicado: (2020)

Evaluation of cumulative prognostic score based on pretreatment plasma fibrinogen and serum albumin levels in patients with newly diagnosed high-grade gliomas
por: He, Zhen-Qiang, et al.
Publicado: (2017)

Prognostic impact of the pretreatment albumin to alkaline phosphatase ratio for nonmetastatic breast cancer patients
por: Long, Zhi-Qing, et al.
Publicado: (2019)

Pretreatment Albumin-to-Fibrinogen Ratio Independently Predicts Chemotherapy Response and Prognosis in Patients with Locally Advanced Rectal Cancer Undergoing Total Mesorectal Excision After Neoadjuvant Chemoradiotherapy
por: Li, Hongzhi, et al.
Publicado: (2020)

Pretreatment C‐reactive protein/albumin ratio is associated with poor survival in patients with stage IB‐IIA cervical cancer
por: Zhang, Weiwei, et al.
Publicado: (2017)

High Pretreatment Platelet-to-Albumin Ratio Predicts Poor Survival Results in Locally Advanced Nasopharyngeal Cancers Treated with Chemoradiotherapy
por: Haksoyler, Veysel, et al.
Publicado: (2021)

Monitoring dynamic cytotoxic chemotherapy response in castration-resistant prostate cancer using plasma cell-free DNA (cfDNA)
por: Patsch, Katherin, et al.
Publicado: (2019)

Associations of cardiovascular biomarkers and plasma albumin with exceptional survival to the highest ages
por: Hirata, Takumi, et al.
Publicado: (2020)

Enhanced expression of FGF19 predicts poor prognosis in patients with non-small cell lung cancer
por: Chen, Jia, et al.
Publicado: (2021)

Low Pretreatment Albumin-to-Globulin Ratios Predict Poor Survival Outcomes in Patients with Head and Neck Cancer: A Systematic Review and Meta-analysis
por: Wang, Yun-Ting, et al.
Publicado: (2023)

Prognostic significance of pretreatment albumin/globulin ratio in patients with hepatocellular carcinoma
por: Deng, Yan, et al.
Publicado: (2016)

Pretreatment Fibrinogen-Albumin Ratio (FAR) Associated with Treatment Response and Survival in Advanced Non-Small Cell Lung Cancer Patients Treated with First-Line Anti-PD-1 Therapy Plus Platinum-Based Combination Chemotherapy
por: Yuan, Chengliang, et al.
Publicado: (2022)

Dynamic alterations of plasma cell free DNA in response to chemotherapy in children with neuroblastoma
por: Su, Yan, et al.
Publicado: (2019)

Preoperative albumin to globulin ratio predicts survival in clear cell renal cell carcinoma patients
por: Chen, Zhen, et al.
Publicado: (2017)

The Pretreatment Albumin to Globulin Ratio Has Predictive Value for Long-Term Mortality in Nasopharyngeal Carcinoma
por: Du, Xiao-Jing, et al.
Publicado: (2014)

Nomograms Predicting Platinum Sensitivity, Progression-Free Survival, and Overall Survival Using Pretreatment Complete Blood Cell Counts in Epithelial Ovarian Cancer
por: Paik, E Sun, et al.
Publicado: (2017)

High pretreatment plasma D-dimer levels are associated with shorter overall survival in patients with small cell lung cancer
por: Fan, Shanshan, et al.
Publicado: (2018)

The association of pretreatment serum albumin with outcomes in bladder cancer: a meta-analysis
por: Li, Jialin, et al.
Publicado: (2018)

Pretreatment values of bilirubin and albumin are not prognostic predictors in patients with advanced pancreatic cancer
por: Feng, Lanyun, et al.
Publicado: (2018)

Prognostic significance of pretreatment serum lactate dehydrogenase-to-albumin ratio in gastric cancer
por: Aday, Ulaş, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_f5tkeq6gdd0nqmjag47902667a